We are monitoring the impact of COVID-19 on Lidocaine Ointment Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 5333
Share on
Share on

Global Lidocaine Ointment Market Analysis - By Formulation (Internal Use And Topical Use), Application (Medical, Cosmetics, & Others) & Region - Industry Analysis, Size, Share, Growth, Trends, Forecast | 2021 to 2026

Pulished: April, 2021
ID: 5333
Pages: 175

Lidocaine Ointment Market Size & Growth (2021 to 2026):

Research analysts at Market Data Forecast predicted the Global Lidocaine Ointment Market size to reach USD 1900 Million by the end of 2026 from USD 1281.2 Million in 2021, exhibiting a CAGR of 8.2% from 2021 to 2026.

Food and Drug Administration (FDA) has approved several topical products, including the prescription NSAID Diclofenac in the form of gels, liquids, and plasters for the treatment of osteoarthritis. The Food and Drug Administration has approved SunGen Pharma for a 5% dose of lidocaine ointment. It is also useful as an anaesthetic lubricant to temporarily relieve pain associated with light burns such as intubation and sunburn, abrasions and insect bites. The market value of the product is approximately USD 60 million. Increased applications of lidocaine as an anti-itch and pain reliever associated with insect bites, small cuts, burns, skin blemishes, male and female urethra, and eczema have fuelled demand. They are providing a wide range of opportunities for the development of the global lidocaine ointment market. 

DRIVERS

The market is expected to grow due to lidocaine ointment in cosmetic operations for pain management associated with cutaneous treatments such as laser surgery, soft tissue augmentation, and other cosmetic procedures. The growing usage of lidocaine as a local anesthetic and cardiac depressant drives the growth of the Lidocaine ointment market. In addition, increased use of lidocaine as an anti-itching and pain reliever for insect bites, minor cuts, burns, skin scrapes, male and female urethra, and eczema has driven demand, propelling the market ahead. Also, the growing geriatric population globally is expected to influence the market growth.

Furthermore, due to an increase in dental operations and the rise in the prevalence of dental caries, the use of lidocaine in dentistry is increasing. Again, the worldwide lidocaine market is progressing owing to an increased diagnosis rate of periodontal diseases. In addition, the demand for pain treatment in cases involving laser surgery and soft tissue augmentation is expected to propel the lidocaine market forward in the coming years.

The factors such as growing disposable income in emerging nations and an increase in public knowledge of preventive healthcare are projected to boost market growth during the forecast period. Moreover, ongoing research and development activities on Lidocaine ointment are more likely to showcase lucrative opportunities for the market growth. Increase in government funding and investments in healthcare sector encourages the market growth.

RESTRAINTS

Government restrictions regulating the safety and efficacy of lidocaine ointment, on the other hand, impede the market growth.

IMPACT OF COVID-19 ON LIDOCAINE OINTMENT MARKET

COVID-19 is an infectious disease caused by the most recent novel coronavirus. As the World Health Organisation (WHO) publicly proclaimed the spread of the virus to be a pandemic, a combination of established pharmaceutical firms and small start-ups have come in to produce drugs and vaccines. As a result, the unexpected emergence of the COVID-19 pandemic has had a positive and negative effect on the pharmaceutical and life sciences industries.

The Lidocaine Ointment market has been negatively affected owing to the reduction in the supply chain, disruption in manufacturing activities, and stringent government guidelines. 

Numerous business players supplying goods and software to the industry have experienced a decrease in the selling of these products and some of the limitations on the imports and exports of the products; these trends have led to the reduction in the consumables and equipment used in the industry which has slowed down the growth of the market. However, with the uplift of the lockdown, the market has gained momentum and is most likely to account for the largest market share during the forecast period. 

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2021 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By Formulation, Application and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

 

This research report on the Global Lidocaine Ointment Market segmented and sub-segmented based on formulation, application and region.

Lidocaine Ointment Market Analysis – By Formulation:

  • Internal Use
  • Topical Use

Lidocaine Ointment Market Analysis – By Application:

  • Cosmetics
  • Medical
  • Others

Based on application, the cosmetic market segment is leading the market due to the implementation of lidocaine ointment in laser surgeries, increasing demand among the public and the emergence of innovative products owing to an escalation in research and development activities in healthcare.

Regional Analysis:

Globally, North America is projected to have a significant share during the forecast period. Due to a rise in surgeries, increased R&D efforts, and increased demand for lidocaine prescriptions, the lidocaine market in North America is witnessing significant growth over the forecast period. Furthermore, due to a growth in the number of cosmetic and plastic surgeons and an increase in healthcare costs, the U.S. market is anticipated to dominate the market during the evaluation period. Healthcare services and medical tourism. The industry's major player focuses on expanding the market; for instance, MilanaPharm, a specialty pharmaceutical company focused on extending innovative, non-opioid pharmaceutical treatments for pain and wound care, received a Notice of Allowance from the United States Patent and Trademark Office. The innovation provides a considerably better administration of lidocaine over a long period, which has never been reported before.

Europe is expected to be the second-largest region for the Lidocaine Ointment Market. A rise in the number of surgical procedures, adoption of lidocaine injections as local anesthetics through the surgeries and a vast population, and major market players such as the UK, Germany, France, and Spain are majorly contributing to the European regional market growth. In 2017, the United Kingdom had a market share of 25.8% in the European lidocaine market.

Asia-Pacific is expected to be the fastest-growing market over the projected period. Due to the expanding elderly population, which is boosting the number of cosmetic treatments, dental procedures, and plastic surgeries. The need for medical tourism and rising healthcare spending is boosting the lidocaine ointment market in this area.

Recent developments in this industry:

In May 2019, MilanaPharm recently announced that it had received a US Patent and Trademark Authorization Notice. The invention provides a remarkably higher distribution of lidocaine over an extended period. The patent is on MilanaPharm's original drug delivery platform, TRI-726. This proprietary technology is to provide a sustained release of an active agent, locally, in a particular region.

In Dec 2018, Strides Pharma Global Pte. Limited has received approval to release 5% of USP lidocaine ointment from the US Food and Drug Administration (FDA). Lidocaine ointment is a standard version of AstraZeneca Pharmaceuticals LP ointment.

 Key market players leading the Global Lidocaine Ointment Market profiled in this report are

  • AstraZeneca Plc.
  • Glenmark Pharmaceuticals
  • Teligent, Inc.
  • Proficient Rx LP
  • Septodont Healthcare India, Pvt. Ltd.
  • Gemini Pharmaceuticals
  • Amneal Pharmaceuticals LLC
  • Taro Pharmaceuticals U.S.A. Inc.
  • Novocol Inc.
  • Centura Pharmaceuticals, Inc.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemiology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Formulation                               

                                5.1.1 Introduction           

                                5.1.2 Internal Use           

                                5.1.3 Topical Use             

                                5.1.4 Y-o-Y Growth Analysis, By Formulation      

                                5.1.5 Market Attractiveness Analysis, By Formulation    

                                5.1.6 Market Share Analysis, By Formulation     

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Cosmetics

                                5.2.3 Medical    

                                5.2.4 Others      

                                5.2.5 Y-o-Y Growth Analysis, By Application         

                                5.2.6 Market Attractiveness Analysis, By Application       

                                5.2.7 Market Share Analysis, By Application        

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Formulation

                                                6.1.3.3 By Application

                                6.1.4 Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Formulation

                                                6.1.4.3 By Application

                                6.1.5 Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Formulation

                                                6.1.5.3 By Application

                6.2 North America                          

                                6.2.1 Introduction           

                                6.2.2 United States         

                                6.2.3 Canada     

                6.3 Europe                         

                                6.3.1 Introduction           

                                6.3.2 U.K             

                                6.3.3 Spain         

                                6.3.4 Germany 

                                6.3.5 Italy            

                                6.3.6 France       

                6.4 Asia-Pacific                 

                                6.4.1 Introduction           

                                6.4.2 China         

                                6.4.3 India          

                                6.4.4 Japan         

                                6.4.5 Australia   

                                6.4.6 South Korea           

                6.5 Latin America                             

                                6.5.1 Introduction           

                                6.5.2 Brazil          

                                6.5.3 Argentina

                                6.5.4 Mexico     

                                6.5.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.6.1 Introduction           

                                6.6.2 Middle-East            

                                6.6.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 AstraZeneca Plc.                       

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Centura Pharmaceuticals, Inc.                            

                8.3 Amneal Pharmaceuticals LLC                               

                8.4 Gemini Pharmaceuticals, Inc.                              

                8.5 Glenmark Pharmaceuticals                  

                8.6 Novocol Inc.                               

                8.7 Proficient Rx LP                         

                8.8 Septodont Healthcare India Pvt. Ltd.                               

                8.9 Taro Pharmaceuticals U.S.A., Inc.                      

                8.10 Teligent, Inc.                            

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, Collaborations, and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures   

  • Global,  and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms product type and Packaged Containers along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Lidocaine Ointment  Market By Region, From 2021 to 2026 ( USD Million )
  2. Global Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  3. Global Internal Use Market By Region, From 2021 to 2026 ( USD Million )
  4. Global Insulin Delivery Market By Region, From 2021 to 2026 ( USD Million )
  5. Global Topical Use Market By Region, From 2021 to 2026 ( USD Million )
  6. Global Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )
  7. Global Cosmetics Market By Region, From 2021 to 2026 ( USD Million )
  8. Global Medical Market By Region, From 2021 to 2026 ( USD Million )
  9. Global Others Market By Region, From 2021 to 2026 ( USD Million )
  10. North America Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  11. North America Internal Use Market By Region, From 2021 to 2026 ( USD Million )
  12. North America Insulin Delivery Market By Region, From 2021 to 2026 ( USD Million )
  13. North America Topical Use Market By Region, From 2021 to 2026 ( USD Million )
  14. North America Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )
  15. North America Cosmetics Market By Region, From 2021 to 2026 ( USD Million )
  16. North America Medical Market By Region, From 2021 to 2026 ( USD Million )
  17. North America Others Market By Region, From 2021 to 2026 ( USD Million )
  18. United States Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  19. United States Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )
  20. Canada Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  21. Canada Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )
  22. Europe Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  23. Europe Internal Use Market By Region, From 2021 to 2026 ( USD Million )
  24. Europe Insulin Delivery Market By Region, From 2021 to 2026 ( USD Million )
  25. Europe Topical Use Market By Region, From 2021 to 2026 ( USD Million )
  26. Europe Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )
  27. Europe Cosmetics Market By Region, From 2021 to 2026 ( USD Million )
  28. Europe Medical Market By Region, From 2021 to 2026 ( USD Million )
  29. Europe Others Market By Region, From 2021 to 2026 ( USD Million )
  30. U.K. Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  31. U.K. Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )
  32. Germany Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  33. Germany Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )
  34. France Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  35. France Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )
  36. Italy Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  37. Italy Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )
  38. Spain Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  39. Spain Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )
  40. Asia Pacific Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  41. Asia Pacific Internal Use Market By Region, From 2021 to 2026 ( USD Million )
  42. Asia Pacific Insulin Delivery Market By Region, From 2021 to 2026 ( USD Million )
  43. Asia Pacific Topical Use Market By Region, From 2021 to 2026 ( USD Million )
  44. Asia Pacific Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )
  45. Asia Pacific Cosmetics Market By Region, From 2021 to 2026 ( USD Million )
  46. Asia Pacific Medical Market By Region, From 2021 to 2026 ( USD Million )
  47. Asia Pacific Others Market By Region, From 2021 to 2026 ( USD Million )
  48. Japan Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  49. Japan Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )
  50. China Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  51. China Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )
  52. India Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  53. India Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )
  54. Australia Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  55. Australia Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )
  56. South Korea Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  57. South Korea Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )
  58. Latin America Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  59. Latin America Internal Use Market By Region, From 2021 to 2026 ( USD Million )
  60. Latin America Insulin Delivery Market By Region, From 2021 to 2026 ( USD Million )
  61. Latin America Topical Use Market By Region, From 2021 to 2026 ( USD Million )
  62. Latin America Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )
  63. Latin America Cosmetics Market By Region, From 2021 to 2026 ( USD Million )
  64. Latin America Medical Market By Region, From 2021 to 2026 ( USD Million )
  65. Latin America Others Market By Region, From 2021 to 2026 ( USD Million )
  66. Brazil Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  67. Brazil Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )
  68. Argentina Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  69. Argentina Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )
  70. Mexico Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  71. Mexico Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )
  72. Rest of Latin America Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  73. Rest of Latin America Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )
  74. Middle East and Africa Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  75. Middle East and Africa Internal Use Market By Region, From 2021 to 2026 ( USD Million )
  76. Middle East and Africa Insulin Delivery Market By Region, From 2021 to 2026 ( USD Million )
  77. Middle East and Africa Topical Use Market By Region, From 2021 to 2026 ( USD Million )
  78. Middle East and Africa Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )
  79. Middle East and Africa Cosmetics Market By Region, From 2021 to 2026 ( USD Million )
  80. Middle East and Africa Medical Market By Region, From 2021 to 2026 ( USD Million )
  81. Middle East and Africa Others Market By Region, From 2021 to 2026 ( USD Million )
  82. Middle East Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  83. Middle East Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )
  84. Africa Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  85. Africa Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample